论文信息 - A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2. - 字舞流文

A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2.

B. Lembersky | R. Miller | D. Friedland | M. Voloshin | B. Zidar | M. Keating | R. Gluckman | J. Cohen | N. Reilly | B. Dimitt